Loading...

Biogen Inc.

0R1B.L•LSE
Healthcare
Medical - Pharmaceuticals
£139.00
£0.02(0.01%)

Biogen Inc. (0R1B.L) Stock Overview

Explore Biogen Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.9/100

Key Financials

Market Cap20.4B
P/E Ratio13.28
EPS (TTM)N/A
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Week$134.74
1 Month$130.68
3 Months$100.28
1 Year Target$122.97

0R1B.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biogen Inc. (0R1B.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $122.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.28 and a market capitalization of 20.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;